Zylox-Tonbridge Medical Technology (2190.HK) Earnings Analysis
Zylox-Tonbridge Medical Technology (2190.HK) next reports earnings on 2026-08-31. Trailing P/E 21.91.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 2190.HK next report earnings?
| Next earnings date | 2026-08-31 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | 0.64B |
2190.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-08-19 | 0.4054 HKD | n/a | n/a | n/a |
| 2025-03-20 | 0.1017 HKD | n/a | n/a | n/a |
| 2024-08-20 | 0.2257 HKD | n/a | n/a | n/a |
2190.HK valuation and analyst view
| Trailing P/E | 21.91 |
|---|---|
| Trailing EPS | 0.75797 HKD |
| Price / book | 1.65 |
| Dividend yield | 1.87% |
| Market cap | 5.99B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Zylox-Tonbridge Medical Technology (2190.HK)'s next earnings date?
Zylox-Tonbridge Medical Technology is next scheduled to report on 2026-08-31 and revenue estimate of 0.64B.
Did 2190.HK beat earnings last quarter?
Consensus estimate data was not available for 2190.HK's 2025-08-19 report.
What is 2190.HK's current P/E ratio and EPS?
2190.HK trades at a trailing P/E of 21.91 on trailing EPS of 0.7579656817856518 HKD.
What do analysts rate 2190.HK?
2190.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.